Happel David

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 54% 68% 82%
Transactions
6 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 82%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Happel David's trades of Sagimet Biosciences Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-22 2026-07-20
S Sale
21,828 -0.7%
431.86
US$1,782,275 		21,828 -0.7% 431.86 US$1,782,275
2026-02-12 2026-02-10
S Sale
38,054 -23.4%
382.91
US$4,526,421 		38,054 -23.4% 382.91 US$4,526,421
2025-07-23 2025-07-21
S Sale
20,846 -17.2%
389.48
US$2,223,621 		20,846 -17.2% 389.48 US$2,223,621
2024-03-28 2024-03-26
B Purchase
12,100 +1.9%
5.27
US$63,731 		12,100 +1.9% 5.27 US$63,731
2023-12-08 2023-12-07
B Purchase
1,600 +0.3%
4.10
US$6,560 		1,600 +0.3% 4.10 US$6,560
2023-11-20 2023-11-16
B Purchase
590 +inf%
2.35
US$1,386 		590 +inf% 2.35 US$1,386